Product Benefits

• Powerful Dual-Action Formula: Combines two distinct classes of antidiabetic agents—Linagliptin (a DPP-4 inhibitor) and Metformin (a biguanide)—to attack high blood sugar from multiple angles.

• Targeted Glucose Regulation: Linagliptin works by increasing active incretin hormones, which stimulate insulin release and decrease glucagon secretion only when blood sugar is high.

• Reduced Liver Sugar Production: Metformin helps lower the amount of sugar produced by the liver and reduces the absorption of glucose from the intestines.

• Enhanced Insulin Sensitivity: Improves the body’s natural response to insulin, allowing peripheral tissues like muscles to use glucose more effectively.

• Lower Risk of Hypoglycemia: When used as directed, this combination is less likely to cause dangerously low blood sugar compared to some other diabetes medications like sulfonylureas.

• Weight Neutrality: Unlike some other diabetic treatments, this combination generally does not cause weight gain, making it easier for patients to manage their metabolic health.

• Convenient Combo Dosing: By combining two medications into one tablet, it simplifies the treatment regimen and improv